Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Information Update

21 Feb 2006 14:48

Aberdeen Growth Opps VCT PLC21 February 2006 ABERDEEN GROWTH OPPORTUNITIES VCT PLC ANNUAL INFORMATION UPDATE Pursuant to the requirements of Prospectus Rule 5.2, the following summarisesthe information that has been published by the Company throughout the twelvemonths ending 20 February 2006. Announcements listed as published on the London Stock Exchange have beenpublished via a Regulatory Information Service and can be found on http://londonstockexchange.com/. (The relevant code for the Company is AGW.) Copies of documents at Companies House, including Report and Accounts, can beobtained from Companies House or through Companies House Direct at http:/www.direct.companieshouse.gov.uk/. Further details may also be obtained from theCompany via its manager at hhtp://www.aberdeen-asset.com/. Report and Accounts can also be inspected at the UK Listing Authority's DocumentViewing Facility at: Financial Services Authority25 The North ColonnadeCanary WharfLondonE14 5HS Tel. 020 7676 1000 Some of the information referred to below was provided as at a specific date andmay now be out of date. Date Description Place of Filing or Publication15-Feb-06 Issue of Equity London Stock Exchange via RNS25-Feb-06 £15m C share Securities Note, Registration aberdeen-asset.co.uk/cshare Document and Summary UKLA Document Viewing Facility27-Jan-06 Doc re Prospectus London Stock Exchange via RNS24-Jan-06 Annual Report and Accounts UKLA Document Viewing Facility30-Dec-05 Final Results London Stock Exchange via RNS22-Dec-05 Result of EGM London Stock Exchange via RNS01-Dec-05 Statement re Portfolio Update London Stock Exchange via RNS29-Nov-05 Transaction in Own Shares London Stock Exchange via RNS18-Nov-05 Circular re C Shares UKLA Document Viewing Facility01-Nov-05 Directorate Change London Stock Exchange via RNS25-Oct-05 Transaction in Own Shares London Stock Exchange via RNS14-Oct-05 Transaction in Own Shares London Stock Exchange via RNS04-Oct-05 Proposed C Share Issue London Stock Exchange via RNS07-Sep-05 Transaction in Own Shares London Stock Exchange via RNS29-Jul-05 Transaction in Own Shares London Stock Exchange via RNS25-Jul-05 Interim Results London Stock Exchange via RNS31-May-05 Investment Activity London Stock Exchange via RNS29-Apr-05 Transaction in Own Shares London Stock Exchange via ROM28-Apr-05 Result of AGM London Stock Exchange via ROM19-Apr-05 Transaction in Own Shares London Stock Exchange via ROM01-Apr-05 Transaction in Own Shares London Stock Exchange via ROM28-Feb-05 Transaction in Own Shares London Stock Exchange via ROM For further information contact: Rosemary O'Neil Company Secretary, Aberdeen Asset Managers Private Equity Telephone: 0141 306 7553 Email: rosemary.o'neil@aberdeen-asset.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.